Annual ROE
-324.20%
-189.37%-140.45%
31 December 2023
Summary:
Xeris Biopharma Holdings annual return on equity is currently -324.20%, with the most recent change of -189.37% (-140.45%) on 31 December 2023. During the last 3 years, it has risen by +54.00% (+14.28%). XERS annual ROE is now -806.01% below its all-time high of 45.92%, reached on 31 December 2017.XERS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
397.13%
-362.11%-47.69%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly return on equity is currently 397.13%, with the most recent change of -362.11% (-47.69%) on 30 September 2024. Over the past year, it has increased by +606.21% (+289.94%). XERS quarterly ROE is now -47.69% below its all-time high of 759.24%, reached on 30 June 2024.XERS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -140.4% | +289.9% |
| 3 y3 years | +14.3% | +193.1% |
| 5 y5 years | +52.6% | +378.6% |
XERS ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -140.4% | +14.3% | -47.7% | +139.0% |
| 5 y | 5 years | -140.4% | +52.6% | -47.7% | +139.0% |
| alltime | all time | -806.0% | +52.6% | -47.7% | +139.0% |
Xeris Biopharma Holdings ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 397.13%(-47.7%) |
| June 2024 | - | 759.24%(-174.5%) |
| Mar 2024 | - | -1019.20%(+181.5%) |
| Dec 2023 | -324.20%(+140.5%) | -362.12%(+73.2%) |
| Sept 2023 | - | -209.08%(+27.5%) |
| June 2023 | - | -163.95%(+26.8%) |
| Mar 2023 | - | -129.34%(-0.0%) |
| Dec 2022 | -134.83%(-29.1%) | -129.37%(-37.9%) |
| Sept 2022 | - | -208.23%(-13.8%) |
| June 2022 | - | -241.47%(-11.3%) |
| Mar 2022 | - | -272.24%(-15.3%) |
| Dec 2021 | -190.28% | -321.60%(-24.6%) |
| Sept 2021 | - | -426.67%(+39.3%) |
| June 2021 | - | -306.33%(+9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -279.18%(-30.2%) |
| Dec 2020 | -378.20%(+35.3%) | -399.80%(-3.2%) |
| Sept 2020 | - | -413.17%(+27.8%) |
| June 2020 | - | -323.33%(+33.4%) |
| Mar 2020 | - | -242.44%(+21.8%) |
| Dec 2019 | -279.56%(-59.1%) | -199.09%(+39.7%) |
| Sept 2019 | - | -142.55%(+38.8%) |
| June 2019 | - | -102.70%(+17.4%) |
| Mar 2019 | - | -87.48%(-25.8%) |
| Dec 2018 | -683.66%(-1588.8%) | -117.86%(+8.3%) |
| Sept 2018 | - | -108.78%(-26.4%) |
| June 2018 | - | -147.83%(-154.6%) |
| Mar 2018 | - | 270.71%(+489.5%) |
| Dec 2017 | 45.92%(+11.0%) | 45.92% |
| Dec 2016 | 41.36% | - |
FAQ
- What is Xeris Biopharma Holdings annual return on equity?
- What is the all time high annual ROE for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual ROE year-on-year change?
- What is Xeris Biopharma Holdings quarterly return on equity?
- What is the all time high quarterly ROE for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly ROE year-on-year change?
What is Xeris Biopharma Holdings annual return on equity?
The current annual ROE of XERS is -324.20%
What is the all time high annual ROE for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual return on equity is 45.92%
What is Xeris Biopharma Holdings annual ROE year-on-year change?
Over the past year, XERS annual return on equity has changed by -189.37% (-140.45%)
What is Xeris Biopharma Holdings quarterly return on equity?
The current quarterly ROE of XERS is 397.13%
What is the all time high quarterly ROE for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly return on equity is 759.24%
What is Xeris Biopharma Holdings quarterly ROE year-on-year change?
Over the past year, XERS quarterly return on equity has changed by +606.21% (+289.94%)